Humira-psoriasis/uveit Starter
My Prescription
Payment
Select pharmacy
$4,770.77
$30.00 due at pharmacy
$4,770.77 - $30.00 = $4,740.77
$4,740.77 remaining balance
You will be given your coupon after you complete your purchase with PayPal.
AlbertsonsPowered by$4,770.77
Print or send this coupon to your phone
AlbertsonsPowered byAbout Humira-psoriasis/uveit Starter
Drug Details
Adalimumab is a medication designed to alleviate pain and swelling associated with various types of arthritis, including rheumatoid, psoriatic, juvenile idiopathic, and ankylosing spondylitis. It also addresses specific skin conditions such as plaque psoriasis and hidradenitis suppurativa. Adalimumab functions by inhibiting a protein in the immune system called tumor necrosis factor (TNF), which is responsible for joint inflammation and damage as well as the development of red, scaly patches in psoriasis. As a TNF blocker, it aims to decrease joint swelling, prevent further joint damage, and maintain joint function. Additionally, Adalimumab is used to treat certain bowel disorders, like Crohn's disease and ulcerative colitis, and an eye condition known as uveitis. This description applies to various forms of Adalimumab, including adalimumab-aacf, adalimumab-aaty, adalimumab-adaz, adalimumab-adbm, adalimumab-afzb, adalimumab-aqvh, adalimumab-atto, adalimumab-bwwd, adalimumab-fkjp, and adalimumab-ryvk.
Price history for Humira-psoriasis/uveit Starter
1 Auto-injector Kit, 80 MG/0.8ML &40MG/0.4ML
Average retail price for Humira-psoriasis/uveit Starter
Average SaveHealth price for Humira-psoriasis/uveit Starter
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Humira-psoriasis/uveit Starter dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 80 MG/0.8ML &40MG/0.4ML | 1 Auto-injector Kit | $4,770.77 | $4,770.77 |
| 80 MG/0.8ML &40MG/0.4ML | 2 Auto-injector Kits | $9,533.54 | $4,766.77 |
| 80 MG/0.8ML &40MG/0.4ML | 3 Auto-injector Kits | $14,296.32 | $4,765.44 |
Humira-psoriasis/uveit Starter FAQs
The cost of a HUMIRA starter kit can vary significantly based on factors such as insurance coverage, pharmacy location, and any available discounts or assistance programs. Without insurance, the price can be quite high, often exceeding several thousand dollars. Patients are encouraged to check with their insurance provider and explore patient assistance programs offered by the manufacturer to potentially reduce out-of-pocket costs.
Yes, while HUMIRA is used to treat certain types of psoriasis, it can paradoxically trigger or worsen psoriasis in some individuals. This is a known but uncommon side effect. If someone experiences new or worsening psoriasis symptoms while taking HUMIRA, they should consult their healthcare provider for evaluation and management.
Humira (adalimumab) is not a cure for uveitis, but it can help manage and reduce the symptoms associated with the condition. It is used to control inflammation and prevent flare-ups, thereby helping to maintain vision and reduce discomfort. Treatment effectiveness can vary, and it is important for patients to follow their healthcare provider's recommendations for managing uveitis.
There are no specific foods that need to be avoided while taking HUMIRA. However, it is important to maintain a balanced diet and follow any dietary recommendations provided by a healthcare provider. Patients should also be cautious about consuming alcohol, as it can interact with medications and affect overall health. If there are any concerns about diet or potential interactions, it is advisable to consult with a healthcare professional.
As of the latest information available, HUMIRA is not being discontinued. It remains a widely used medication for various inflammatory conditions. However, patients should always consult with their healthcare provider for the most current information regarding their medications.